These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5034812)

  • 41. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 42. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibiotics produced by Streptomyces spinichromogenes var. kujimyceticus. 4. Therapeutic effects of kujimycins A and B in experimental infections in mice].
    Namiki S; Omura S; Shibata M; Muro T; Sawada J
    Jpn J Antibiot; 1970 Jun; 23(3):279-86. PubMed ID: 5312213
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.
    Silverman JA; Mortin LI; Vanpraagh AD; Li T; Alder J
    J Infect Dis; 2005 Jun; 191(12):2149-52. PubMed ID: 15898002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical and experimental studies on a new aminoglycoside antibiotic, lividomycin].
    Iwasawa T
    Jpn J Antibiot; 1972 Dec; 25(6):472-83. PubMed ID: 4541925
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibacterial nitrofuran derivatives. 2. 5-Nitro-2-furaldehyde aminoacethydrazones.
    Massarani E; Nardi D; Tajana A; Degen L
    J Med Chem; 1971 Jul; 14(17):633-5. PubMed ID: 5005988
    [No Abstract]   [Full Text] [Related]  

  • 47. [Correlation of resistance of Staphylococcus aureus and Klebsiella friedlender to monomycin in vitro and in vivo].
    Dratvin SA
    Antibiotiki; 1966 Jun; 11(6):552-7. PubMed ID: 4871258
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute coalescent mastoiditis caused by antibiotic resistant organisms.
    Collison PJ; Farver D
    S D J Med; 1998 Oct; 51(10):379-83. PubMed ID: 9803164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.
    Waitz JA; Drube CG; Moss EL; Weinstein MJ
    J Antibiot (Tokyo); 1972 Nov; 25(11):647-52. PubMed ID: 4486485
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
    Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
    Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibiotics for hand infections.
    Downing BT
    Lancet; 1973 May; 1(7813):1184. PubMed ID: 4123569
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial agents--mechanisms of action and clinical usage.
    Neu HC
    Curr Probl Surg; 1973 Jun; ():1-64. PubMed ID: 4146368
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of staphylococcal septicemias].
    Josan R; Gavrilă I; Pîrvu C; Procopan V
    Med Interna (Bucur); 1971 Nov; 23(11):1337-44. PubMed ID: 5134695
    [No Abstract]   [Full Text] [Related]  

  • 54. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Further Novara contribution on the antibiotic resistance of pyogenic staphylococci].
    Fumagalli E
    G Mal Infett Parassit; 1970 Feb; 22(2):150-4. PubMed ID: 4929950
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clomethacillin. Synthesis and antibacterial properties].
    Rudzit EA; Pleshakov MG; Radkevich TP; Kulikova DA; Avidon VV
    Antibiotiki; 1974 Oct; 19(10):887-90. PubMed ID: 4218940
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of protein binding on antibiotic activity in vivo.
    Merrikin DJ; Briant J; Rolinson GN
    J Antimicrob Chemother; 1983 Mar; 11(3):233-8. PubMed ID: 6841305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms].
    Giunchi G
    Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414
    [No Abstract]   [Full Text] [Related]  

  • 59. Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity.
    Surivet JP; Lange R; Hubschwerlen C; Keck W; Specklin JL; Ritz D; Bur D; Locher H; Seiler P; Strasser DS; Prade L; Kohl C; Schmitt C; Chapoux G; Ilhan E; Ekambaram N; Athanasiou A; Knezevic A; Sabato D; Chambovey A; Gaertner M; Enderlin M; Boehme M; Sippel V; Wyss P
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6705-11. PubMed ID: 23006603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.